Advertisement
National Cancer Institute-designated cancer centers are endorsing the goal of eliminating cancers caused by the human papillomavirus (HPV) through HPV vaccination and evidence-based cancer screening

NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers

0
HPV vaccine, screening offer opportunity to prevent 12,000 cervical CAs, 40,000 HPV-linked CAs/year
The prevalence of being uninsured varies by occupational groups

CDC: Prevalence of No Insurance Varies by Occupational Groups

0
Significant drop in prevalence of uninsured from 2013 to 2014; variation by occupation in both years
Three assays may detect early lung cancer in blood samples using genome sequencing

ASCO: New Assays May Detect Early Lung Cancer in Blood

0
Targeted sequencing, whole-genome sequencing, whole-genome bisulfite sequencing show potential
The lifetime risks of Alzheimer's disease dementia vary considerably by age

Lifetime Risks Temper Biomarker Tests for Alzheimer Dz Dementia

0
Those younger than 85 years with MCI, amyloidosis, neurodegeneration have risk >50 percent
The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer

ASCO: Ovarian Suppression + Tamoxifen Ups Breast CA Survival

0
Increased disease-free, overall survival for premenopausal women with breast cancer
A considerable proportion of breast cancer survivors do not undergo annual surveillance breast imaging

Many Breast Cancer Survivors Do Not Undergo Annual Surveillance

0
In year 1, 13 percent did not undergo MRI or mammography; up to 19 percent by year 5
A highly personalized therapy targeting multiple tumor antigens shows promise for metastatic breast cancer

Personalized Therapy Promising in Metastatic Breast Cancer

0
Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression
For women with hormone-receptor-positive

ASCO: Endocrine Tx Noninferior for HR+, HER2− Breast Cancer

0
Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score

May 2018 Briefing – Pathology

0
Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2018. This roundup includes the latest...
The diagnostic performance of a deep learning convolutional neural network seems better than that of dermatologists

Convolutional Neural Network Tops Clinicians for Melanoma ID

0
CNN receiver operating characteristic curve had higher specificity compared with dermatologists'